FHAM
NDRM

Folger Hill Asset Management’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

Folger Hill Asset Management’s Portfolio NDRM Stock Details NDRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-65,913
Closed -$1.22M – 399
2016
Q3 		$1.22M Hold
65,913
– – 0.07% 209
2016
Q2 		$1.07M Hold
65,913
– – 0.08% 149
2016
Q1 		$931K Hold
65,913
– – 0.05% 145
2015
Q4 		$1.12M Buy
+65,913
New +$1.28M 0.07% 172

Other funds holding NDRM

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Folger Hill Asset Management's NDRM Position: Q4 2016 in Review

Folger Hill Asset Management sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q4 2016, closing a stake of 65,913 shares — an estimated $1.22M sold.

Folger Hill Asset Management first reported a position in NDRM in Q4 2015 and held it in 4 quarters. The position peaked at $1.22M in Q3 2016. 56 funds tracked by Wall St. Rank hold NDRM as of Q4 2016.

  • Folger Hill Asset Management reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q4 2016 after selling out during the quarter.
  • Folger Hill Asset Management sold 65,913 NeuroDerm Ltd. Ordinary Shares shares in Q4 2016, an estimated $1.22M.
  • Folger Hill Asset Management first reported a position in NeuroDerm Ltd. Ordinary Shares in Q4 2015 and held it in 4 quarters.
  • Folger Hill Asset Management's NeuroDerm Ltd. Ordinary Shares position peaked at $1.22M in Q3 2016.
  • 56 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q4 2016.

Based on Folger Hill Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.